BioProcess International is part of the Informa Connect Division of Informa PLC

Informa PLC|ABOUT US|INVESTOR RELATIONS|TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BPI Events About Subscribe Contribute

Upstream

Recent in Upstream

See all

Comprehensive risk assessment framework

Biochemicals/Raw Materials

Buffer and Solution Mixing-Time Validation: A Risk-Assessment Framework for Analysts Using Matrix and Bracketing Approaches Buffer and Solution Mixing-Time Validation: A Risk-Assessment Framework for Analysts Using Matrix and Bracketing Approaches

byNaveenganesh Muralidharan, Leya S. Roseand 6 more

Jan 29, 2025

thumbnail

Bioreactors

Lessons in Bioreactor Scale-Up, Part 5: Theoretical and Empirical Correlations for Predicting the Mass-Transfer Coefficient in Stirred-Tank Bioreactors Lessons in Bioreactor Scale-Up, Part 5: Theoretical and Empirical Correlations for Predicting the Mass-Transfer Coefficient in Stirred-Tank Bioreactors

byMuhammad Arshad Chaudhry

Jan 29, 2025

Downstream

Recent in Downstream

See all

Bio-Rad BPI Ask the Expert Webcast

Sponsored Content

Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process

byBPI Contributor

Jan 28, 2025

15 Min View

Nagase special report

Sponsored Content

Advanced Saccharide Solutions in Biopharmaceutical Development: Paving the Way for Product Stability and Environmental Sustainability Advanced Saccharide Solutions in Biopharmaceutical Development: Paving the Way for Product Stability and Environmental Sustainability

byYosuke Shimojo, Toshio Ariyasuand 1 more

Dec 9, 2024

Manufacturing

Recent in Manufacturing

See all

elucidation

Careers & Training

A Key Talent and Expertise Required for Continuous Versus Batch Biomanufacturing A Key Talent and Expertise Required for Continuous Versus Batch Biomanufacturing

byJason Beckwith, William Nixonand 2 more

Jan 29, 2025

Comprehensive risk assessment framework

Biochemicals/Raw Materials

byNaveenganesh Muralidharan, Leya S. Roseand 6 more

Jan 29, 2025

Analytical

Recent in Analytical

See all

Example upstream cell-culture process

Contract Services

Technology Transfer for Outsourced Programs: Highlighting Upstream Considerations Technology Transfer for Outsourced Programs: Highlighting Upstream Considerations

byNikki Nogal

Jan 29, 2025

Comprehensive risk assessment framework

Biochemicals/Raw Materials

byNaveenganesh Muralidharan, Leya S. Roseand 6 more

Jan 29, 2025

Business

Recent in Business

See all

elucidation

Careers & Training

A Key Talent and Expertise Required for Continuous Versus Batch Biomanufacturing A Key Talent and Expertise Required for Continuous Versus Batch Biomanufacturing

byJason Beckwith, William Nixonand 2 more

Jan 29, 2025

Example upstream cell-culture process

Contract Services

Technology Transfer for Outsourced Programs: Highlighting Upstream Considerations Technology Transfer for Outsourced Programs: Highlighting Upstream Considerations

byNikki Nogal

Jan 29, 2025

Therapeutic Modalities

Recent in Therapeutic Modalities

See all

scientists on greenhouse

Emerging Therapeutics

Recombinant Human Collagen: Plant-Based Production Addresses Growing Demand for a Vegan Option Recombinant Human Collagen: Plant-Based Production Addresses Growing Demand for a Vegan Option

byBarry Gunn

Jan 29, 2025

Antibody-Drug Conjugate eBook

Sponsored Content

eBook: Antibody-Drug Conjugates — A Technology Update eBook: Antibody-Drug Conjugates — A Technology Update

byShreeyashi Ojha, Josh Abbottand 4 more

Jan 24, 2025

BioProcess Insider

Recent in BioProcess Insider

See all

A photograph of David Hamer

Facilities & Capacity

Cold chain infrastructure hangs over bird flu vaccine prep Cold chain infrastructure hangs over bird flu vaccine prep

bySøren Hough

Feb 4, 2025

3 Min Read

A picture of Capitol Hill at sunset

Regulations

Vaccine skeptic Kennedy advances in bid to lead HHS Vaccine skeptic Kennedy advances in bid to lead HHS

byJosh Abbott

Feb 4, 2025

4 Min Read

Economics

The Next Five Years — and MoreThe Next Five Years — and More

BPI Contributor

October 1, 2007

1 Min Read

The Next Five Years — and More

Subscribe to receive our monthly print or digital publication

Join our 70,000+ readers. And yes, it's completely free.

Webinars

Ask the Expert webcasts

ATE Webcasts

Register Now: Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process

Event Report

Exclusive eBook

eBook: Biotech Week Boston Post-event Report

Read Now

Insider News

Cold chain infrastructure hangs over bird flu vaccine prep
Feb 4, 2025
|
3 Min Read
Vaccine skeptic Kennedy advances in bid to lead HHS
Feb 4, 2025
|
4 Min Read
Lantheus goes Evergreen in a $250m upfront deal
Feb 4, 2025
|
1 Min Read
Cell mates: SCTbio, CCRM Nordic amp up cell therapy production
Feb 4, 2025
|
1 Min Read

See all

Mar 18 - Mar 21, 2025

SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.

Learn More